Seqirus AFLURIA QUADRIVALENT 0.5ml , 10 Pre-filled Syringes

Description

AFLURIA QUADRIVALENT

Key Features

• Administer as a 0.25-mL dose for patients 6 through 35 months, and as a 0.5-mL dose for patients 36 months through 8 years as 1 or 2* doses¹
• Demonstrated immunogenicity in children and adults¹
• Demonstrated safety profile¹
• Produced through traditional egg-based manufacturing¹

*1 or 2 doses depends on vaccination history as per Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza with vaccines.